Patent details

EP3441069 Title: TREATMENT OF DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS

Basic Information

Publication number:
EP3441069
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP181887993
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF DIABETIC RETINOPATHY USING PHARMACEUTICAL AGENTS THAT ELIMINATE SENESCENT CELLS
French Title of Invention:
TRAITEMENT DE LA RÉTINOPATHIE DIABÉTIQUE À L'AIDE D'AGENTS PHARMACEUTIQUES QUI PERMETTENT DE SUPPRIMER DES CELLULES SÉNESCENTES
German Title of Invention:
BEHANDLUNG VON DIABETISCHER RETINOPATHIE MIT PHARMAZEUTISCHEN WIRKSTOFFEN ZUR ELIMINIERUNG SENESZENTER ZELLEN
SPC Number:

Dates

Filing date:
13/08/2018
Grant date:
05/04/2023
EP Publication Date:
13/02/2019
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/04/2023
EP B1 Publication Date:
05/04/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/08/2023
Expiration date:
13/08/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
29/03/2023
 
 

Name:
Unity Biotechnology, Inc.
Address:
285 East Grand Avenue, South San Francisco, CA 94080, United States (US)

Inventor

1

Name:
Laberge, Remi-Martin
Address:
United States (US)

2

Name:
Sweigard, Harry
Address:
United States (US)

3

Name:
David, Nathaniel
Address:
United States (US)

4

Name:
Marquess, Daniel
Address:
United States (US)

5

Name:
Poon, Yan
Address:
United States (US)

6

Name:
Dananberg, Jamie
Address:
United States (US)

7

Name:
Tsuruda, Pam
Address:
United States (US)

8

Name:
Hopkins, Jill
Address:
United States (US)

9

Name:
Chapman, Claude
Address:
United States (US)

Priority

1

Priority Number:
201715675171
Priority Date:
11/08/2017
Priority Country:
United States (US)

2

Priority Number:
201762579793 P
Priority Date:
31/10/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/496; A61K 31/675; A61P 27/02; A61P 27/06;

Publication

European Patent Bulletin

1

Issue number:
202314
Publication date:
05/04/2023
Description:
Grant (B1)

2

Issue number:
202319
Publication date:
10/05/2023
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages